This article explains why Levity is stopping the sale of compounded semaglutide products, what happens to existing paid orders, what happens to active subscriptions, and what treatment options Levity is exploring next. Use this article if you are a Levity patient currently using compounded semaglutide, waiting for a paid compounded semaglutide order, or looking for next steps after this change.
First, we want to thank you for your patience and understanding as Levity navigated several regulatory and supply challenges over the past few months.
Unfortunately, as of Wednesday, April 30, 2025, Levity will no longer be able to sell any compounded products containing semaglutide, including compounded semaglutide formulations combined with B12 and Glycine.
Any compounded semaglutide products that have already been paid for will still be shipped and delivered as planned.
This change follows the FDA’s February 2025 decision announcing the end of the semaglutide shortage. Like many Levity patients, we were surprised by this development, especially given the ongoing high cost and limited access to branded GLP-1 medications.
Since the FDA’s February 2025 decision, Levity has explored every possible legal and clinical avenue to continue supporting patient treatment. Levity’s highest priority has always been to ensure continuity of care for existing customers. Despite Levity’s best efforts, Levity has not been able to identify a viable path forward that allows Levity to continue offering compounded semaglutide.
Levity understands how crucial compounded semaglutide treatment has been for your health journey and how frustrating and disheartening this news may feel. Please accept Levity’s heartfelt apology for this disruption. Levity understands how personal and important this treatment is, and Levity never takes that trust lightly.
While this chapter is coming to a close, Levity remains focused on finding new ways to support your weight loss journey. One option Levity is working to make available soon is liraglutide, an effective GLP-1 medication that may offer an affordable and accessible path for weight loss and weight management. Levity is committed to expanding access to treatment options that fit a variety of needs and budgets.
If you have any questions or need support navigating your next steps, please reach out to Levity. Levity is here for you.
1. Why is Levity stopping the sale of compounded semaglutide?
Levity is stopping the sale of compounded semaglutide following the FDA’s February 2025 decision to declare an end to the semaglutide shortage and following subsequent regulatory advice Levity received.
Based on the FDA decision and regulatory advice, it is no longer legally viable for Levity to continue offering compounded semaglutide products in the US market.
2. When is the last day I can receive compounded semaglutide from Levity?
Levity is stopping compounded semaglutide sales as of April 30, 2025.
Any compounded semaglutide orders already paid for will still be processed and shipped as planned.
3. What happens to my active compounded semaglutide subscription?
All active compounded semaglutide subscriptions will be automatically cancelled on April 30, 2025.
You do not need to take any action to cancel your active compounded semaglutide subscription.
4. Will I still receive the compounded semaglutide order I already paid for?
Yes. Any compounded semaglutide orders that have already been processed and paid for will still be shipped and delivered as expected.
5. Can I place a last-minute compounded semaglutide order before April 30?
Yes. You can place a compounded semaglutide order until April 30, 2025.
Please expect processing and shipping delays for last-minute compounded semaglutide orders.
6. Will Levity offer compounded semaglutide again in the future?
At this time, Levity does not anticipate offering compounded semaglutide again, at least until there are updates in the regulations.
Levity is actively exploring alternative treatment options, including liraglutide and other potential treatments.
7. What product alternatives is Levity working on?
Levity is currently developing alternative treatment options, including Compounded Liraglutide and other treatments that could offer safe and compliant alternatives for Levity customers.
Levity will keep customers updated as soon as these alternative treatment options are available.
8. Why can’t Levity keep selling compounded semaglutide if there is still demand?
Levity recognizes the extensive demand for affordable, safe, and effective GLP-1 treatments.
However, Levity made this decision because of the FDA’s February 2025 decision to declare an end to the semaglutide shortage and because of subsequent regulatory advice Levity received.
Despite Levity’s best efforts, Levity has not been able to identify a viable path forward that allows Levity to continue offering compounded semaglutide.
9. Why can’t Levity keep selling compounded semaglutide like other companies?
After the FDA declared the semaglutide shortage over, every company sought its own legal advice and designed its own strategy.
Levity explored many clinical and legal avenues. Unfortunately, Levity could not find a viable solution that would allow Levity to continue selling compounded semaglutide.
10. I need ongoing treatment. What should I do next?
Levity understands how important it is to continue your treatment without interruption.
Levity’s team is actively working on introducing new affordable and effective options, such as liraglutide. Levity will be in touch very soon with more details about new treatment options.
If you need immediate support, Levity recommends speaking with your healthcare provider.
11. What is liraglutide?
Liraglutide is a prescription medication that belongs to the GLP-1 receptor agonist family, like semaglutide.
Liraglutide is clinically proven to support weight management and blood sugar control. Liraglutide is the active ingredient in medications such as Saxenda®, which is approved for weight loss.
Liraglutide works in a similar way to semaglutide, but liraglutide is typically dosed daily rather than weekly.
12. I feel frustrated or disappointed by this change. What should I know?
Levity completely understands how frustrating and disappointing this news can feel.
Levity never takes your trust lightly. Levity made this decision only after exhausting every possible option to continue supporting your treatment within the law.
Levity’s team is here to listen and help however Levity can during this transition.
13. Why is Levity notifying patients now with such short notice?
Levity notified customers as soon as Levity finalized the necessary legal and operational steps following the FDA’s announcement and subsequent phases of regulatory advice.
Levity wanted to be absolutely sure Levity explored every possible solution before communicating this change.
Levity understands that this short notice is frustrating. Levity is doing everything possible to bring new treatments online soon.
If you still need help after reviewing the information above, additional assistance is available